This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms or myelodysplastic syndromes. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative neoplasms or myelodysplastic syndromes. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.

The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in myeloproliferative neoplasms or myelodysplastic syndromes that are not listed here.